Mid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosis

Mid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosis

Show other versions (1)

Heart failure has a high prevalence in developed countries. It is a frequent cause of hospital admission and has an important impact on morbidity, mortality and healthcare costs. Biomarkers have been widely studied in heart failure, as they improve diagnosis and prognostic assessment. Natriuretic pe...

Full description

Bibliographic Details
Main Authors:	Daniela Lopes, Luiz Menezes Falcão
Format:	Article
Language:	English
Published:	Elsevier 2017-06-01
Series:	Revista Portuguesa de Cardiologia (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2174204917301745

Similar Items

Mid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosis
by: Daniela Lopes, et al.
Published: (2017-06-01)

Procalcitonin and mid-regional pro-adrenomedullin as promising markers for sepsis diagnosis and prognosis
by: Silvia Angeletti, et al.
Published: (2016-11-01)

The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort.
by: Ghazaleh Gouya, et al.
Published: (2011-01-01)

Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study.
by: Bruno Viaggi, et al.
Published: (2018-01-01)

Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study
by: Dres M, et al.
Published: (2017-03-01)

Correlation between Serum Mid-Regional Pro-Adrenomedullin and Sequential Organ Failure Assessment (SOFA) Score in Patient with Sepsis
by: Hapsari Pujiyanti, et al.
Published: (2019-06-01)

Mid-regional pro-adrenomedullin is a novel biomarker for arterial stiffness as the criterion for vascular failure in a cross-sectional study
by: Teruhide Koyama, et al.
Published: (2021-01-01)

Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
by: Uğur Önal, et al.
Published: (2018-09-01)

Author Correction: Mid-regional pro-adrenomedullin is a novel biomarker for arterial stiffness as the criterion for vascular failure in a cross-sectional study
by: Teruhide Koyama, et al.
Published: (2021-08-01)

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.
by: Giorgia Montrucchio, et al.
Published: (2021-01-01)

Plasma concentrations of the vasoactive peptide fragments mid-regional pro-adrenomedullin, C-terminal pro-endothelin 1 and copeptin in hemodialysis patients: associated factors and prediction of mortality.
by: Ferruh Artunc, et al.
Published: (2014-01-01)

Pro-adrenomedullin level in chronic forms of coronary heart disease: relationship with systolic function of the left ventricle
by: E I Myasoedova, et al.
Published: (2019-06-01)

Regulation of adrenomedullin gene expression in the rat heart
by: Romppanen, H. (Hannu)
Published: (1999)

A protocol for a systematic review and meta-analysis of the diagnostic accuracy of mid-regional pro-adrenomedullin in predicting invasive bacterial infection in children
by: Michael Corr, et al.
Published: (2020-04-01)

Heart failure in elderly with focus on diagnosis and prognosis
by: Olofsson, Mona
Published: (2015)

Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis
by: Rosa Zampino, et al.
Published: (2021-01-01)

The Role of Adrenomedullin in the Renal NADPH Oxidase and (Pro)renin in Diabetic Mice
by: Michio Hayashi, et al.
Published: (2013-01-01)

Plasma bio-adrenomedullin is a marker of acute heart failure severity in patients with acute coronary syndrome
by: Mattia Arrigo, et al.
Published: (2019-03-01)

Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score
by: Travaglino Francesco, et al.
Published: (2012-08-01)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
by: Christopher Geven, et al.
Published: (2018-02-01)

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
by: Luca Branca, et al.
Published: (2020-04-01)

Plasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke.
by: Thomas Seifert-Held, et al.
Published: (2013-01-01)

The Value of Biomarkers in the Diagnosis and Prognosis of Heart Failure in Older Age
by: V. N. Larina, et al.
Published: (2021-03-01)

Prognosis of Developing Heart Failure Following ST Elevation (STEMI) and Non ST Elevation (NSTEMI) Infarct
by: A Torabi, et al.
Published: (2005-10-01)

Prognosis of Developing Heart Failure Following ST Elevation (STEMI) and Non ST Elevation (NSTEMI) Infarct
by: A Torabi, et al.
Published: (2005-03-01)

Pro-atrial natriuretic peptide and pro-adrenomedullin before cardiac surgery in children. Can we predict the future?
by: Sara Bobillo-Perez, et al.
Published: (2020-01-01)

Adrenomedullin and cardiovascular diseases
by: Hoi Kin Wong, et al.
Published: (2012-08-01)

Adrenomedullin on digestive tract
by: Fukuda, Kazuhito
Published: (2011)

Copeptin, myeloperoxidase and pro-adrenomedullin for acute coronary syndrome in patients with chronic kidney disease
by: Jen Heng Pek, et al.
Published: (2019-09-01)

The Role of Pro-Adrenomedullin as a Marker of Severe Bacterial Infection in Children: A Review
by: Silvia Garazzino, et al.
Published: (2019-07-01)

A Multiparametric Approach Based on NT-proBNP, ST2, and Galectin3 for Stratifying One Year Prognosis of Chronic Heart Failure Outpatients
by: Dario Grande, et al.
Published: (2017-07-01)

The Relationship between Serum NT– Pro-BNP Levels and Prognosis in Patients with Systolic Heart Failure
by: Sepideh Sokhanvar, et al.
Published: (2011-05-01)

The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19
by: Radu-Stefan Miftode, et al.
Published: (2021-01-01)

Epidemiology and Prognosis of Heart Failure
by: Ilaria Spoletini, et al.
Published: (2017-01-01)

Hemodynamic and hormonal actions of adrenomedullin
by: M.G. Nicholls
Published: (2004-08-01)

Effect of adrenomedullin on the cutaneous microvasculature
by: Chu, Duc Quyen
Published: (2003)

Adrenomedullin and the Defence of the Oral Cavity
by: Sheehan, Barry Edward
Published: (2008)

Regulation and neutralisation of adrenomedullin in cancer
by: Ashok Kumar, Mary Brindha
Published: (2014)

Adrenomedullin, PAMP and adrenocortical function
by: Thomson, Laura Margaret
Published: (2001)

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
by: Chao Ma, et al.